Lisa Browning
Overview
Explore the profile of Lisa Browning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
372
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lombardi O, Li R, Jabbar F, Evans H, Halim S, Lima J, et al.
Cell Rep
. 2025 Jan;
44(1):115169.
PMID: 39792555
Clear cell kidney cancers are characterized both by conserved oncogenic driver events and by marked intratumor genetic and phenotypic heterogeneity, which help drive tumor progression, metastasis, and resistance to therapy....
2.
Anbarasan T, Raslan M, Ghosh K, Macklin P, Mercader C, Leslie T, et al.
BJUI Compass
. 2024 Sep;
5(9):834-836.
PMID: 39323925
No abstract available.
3.
Mohanty S, Lobo A, Jha S, Sangoi A, Akgul M, Trpkov K, et al.
Virchows Arch
. 2024 Sep;
485(5):829-840.
PMID: 39287823
Oncocytic renal neoplasms are a major source of diagnostic challenge in genitourinary pathology; however, they are typically nonaggressive in general, raising the question of whether distinguishing different subtypes, including emerging...
4.
Lobo A, Collins K, Kaushal S, Acosta A, Akgul M, Adhya A, et al.
Histopathology
. 2024 Jul;
85(5):748-759.
PMID: 39075659
Aims: Urothelial carcinoma (UC) demonstrates significant molecular and histologic heterogeneity. The WHO 2022 classification has hinted at adding molecular signatures to the morphologic diagnosis. As morphology and associated molecular repertoire...
5.
Culliford R, Lawrence S, Mills C, Tippu Z, Chubb D, Cornish A, et al.
Nat Commun
. 2024 Jul;
15(1):5935.
PMID: 39009593
Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer, but a comprehensive description of its genomic landscape is lacking. We report the whole genome sequencing...
6.
Browning L, Jesus C, Malacrino S, Guan Y, White K, Puddle A, et al.
Diagnostics (Basel)
. 2024 May;
14(10).
PMID: 38786288
Digital pathology continues to gain momentum, with the promise of artificial intelligence to aid diagnosis and for assessment of features which may impact prognosis and clinical management. Successful adoption of...
7.
Bates A, Sharma A, Camilleri P, Browning L, Verrill C, Hamdy F
BJU Int
. 2024 Apr;
134(3):377-379.
PMID: 38644731
No abstract available.
8.
Rao S, Protheroe A, Cerundolo L, Maldonado-Perez D, Browning L, Lamb A, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37628903
Prostate cancer is typically of acinar adenocarcinoma type but can occasionally present as neuroendocrine and/or ductal type carcinoma. These are associated with clinically aggressive disease, and the former often arises...
9.
Kelleher M, Colling R, Browning L, Roskell D, Roberts-Gant S, Shah K, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443538
Aim: we describe our experience of validating departmental pathologists for digital pathology reporting, based on the UK Royal College of Pathologists (RCPath) "Best Practice Recommendations for Implementing Digital Pathology (DP),"...
10.
Browning L, White K, Siiankoski D, Colling R, Roskell D, Fryer E, et al.
Front Med (Lausanne)
. 2022 Aug;
9:933933.
PMID: 35979219
Digital pathology (DP) offers potential for time efficiency gains over an analog workflow however, to date, evidence supporting this claim is relatively lacking. Studies available concentrate on specific workflow points...